Articles

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis

Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria
Otto Loewi Research Center, Immunology and Pathophysiology, Medical University of Graz, Graz, Austria
Otto Loewi Research Center, Immunology and Pathophysiology, Medical University of Graz, Graz, Austria
Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
5th Medical Department with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria;Sigmund Freud University, Vienna, Austria
Institute of Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria
Systems Biology Ireland and Conway Institute, University College Dublin, Dublin, Ireland
Cancer Research UK Beatson Institute, Glasgow, UK
Cancer Research UK Beatson Institute, Glasgow, UK
Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria
Division of Hematology, Medical University of Graz, Graz, Austria;Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2018.209650